Gandhi, A. K., Mendy, D., Waldman, M., Chen, G., Rychak, E., Miller, K., . . . Chopra, R. (2014). Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity. Br J Haematol.
Citación estilo ChicagoGandhi, Anita K., et al. "Measuring Cereblon As a Biomarker of Response or Resistance to Lenalidomide and Pomalidomide Requires Use of Standardized Reagents and Understanding of Gene Complexity." Br J Haematol 2014.
Cita MLAGandhi, Anita K., et al. "Measuring Cereblon As a Biomarker of Response or Resistance to Lenalidomide and Pomalidomide Requires Use of Standardized Reagents and Understanding of Gene Complexity." Br J Haematol 2014.